DK1748779T3 - Transdermal steroidformulering - Google Patents

Transdermal steroidformulering

Info

Publication number: DK1748779T3
Authority: DK; Denmark
Prior art keywords: sup; group; weight; steroid formulation; acrylate
Prior art date: 2004-04-28

Application number

DK05738733.4T

Other languages

English (en)

Inventor

James Robert Murray

Fumio Kamiyama

Ernst Wuelfert

Original Assignee

Hunter Fleming Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-28

Filing date

2005-04-28

Publication date

2010-12-13

2005-04-28 Application filed by Hunter Fleming Ltd filed Critical Hunter Fleming Ltd

2010-12-13 Application granted granted Critical

2010-12-13 Publication of DK1748779T3 publication Critical patent/DK1748779T3/da

Links

238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
150000003431 steroids Chemical class 0.000 title 1
HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 abstract 1
239000000853 adhesive Substances 0.000 abstract 1
230000001070 adhesive effect Effects 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000004104 aryloxy group Chemical group 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229920001577 copolymer Polymers 0.000 abstract 1
GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 abstract 1
239000000178 monomer Substances 0.000 abstract 1
125000004043 oxo group Chemical group O=* 0.000 abstract 1
125000003396 thiol group Chemical group [H]S* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK05738733.4T 2004-04-28 2005-04-28 Transdermal steroidformulering DK1748779T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0409498.3A GB0409498D0 (en)	2004-04-28	2004-04-28	Transdermal steroid formulation
PCT/GB2005/001596 WO2005105104A1 (en)	2004-04-28	2005-04-28	Transdermal steroid formulation

Publications (1)

Publication Number	Publication Date
DK1748779T3 true DK1748779T3 (da)	2010-12-13

Family

ID=32408193

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05738733.4T DK1748779T3 (da)	2004-04-28	2005-04-28	Transdermal steroidformulering

Country Status (24)

Country	Link
US (1)	US20070231373A1 (da)
EP (1)	EP1748779B1 (da)
JP (1)	JP4849478B2 (da)
KR (1)	KR101139023B1 (da)
CN (1)	CN1997375B (da)
AT (1)	ATE480241T1 (da)
AU (1)	AU2005237285B2 (da)
CA (1)	CA2563830C (da)
CY (1)	CY1111318T1 (da)
DE (1)	DE602005023436D1 (da)
DK (1)	DK1748779T3 (da)
ES (1)	ES2352202T3 (da)
GB (1)	GB0409498D0 (da)
HR (1)	HRP20100558T1 (da)
IL (1)	IL178781A (da)
NO (1)	NO337073B1 (da)
NZ (1)	NZ550784A (da)
PL (1)	PL1748779T3 (da)
PT (1)	PT1748779E (da)
RU (1)	RU2371183C2 (da)
SI (1)	SI1748779T1 (da)
TW (1)	TWI354557B (da)
WO (1)	WO2005105104A1 (da)
ZA (1)	ZA200608878B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0523550D0 (en) *	2005-11-18	2005-12-28	Hunter Fleming Ltd	Therapeutic uses of steroidal compounds
HRP20120687T1 (hr) *	2006-11-30	2012-09-30	Hunter-Fleming Limited	Moduliranje metabolizma prostaglandina/ciklooksigenaze

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3238389B2 (ja) *	1988-10-27	2001-12-10	シエーリングアクチエンゲゼルシヤフト	ゲストデン含有の経皮適用のための薬剤
US4978532A (en) *	1989-08-11	1990-12-18	Pharmedic Co.	Dosage form for administration of dehydroepiandrosterone
US5565444A (en) *	1993-05-18	1996-10-15	Ltt Institute Co., Ltd.	Osteogenesis promoter and osteoporosis remedy
US5460820B1 (en) *	1993-08-03	1999-08-03	Theratech Inc	Method for providing testosterone and optionally estrogen replacement therapy to women
DE4405898A1 (de) *	1994-02-18	1995-08-24	Schering Ag	Transdermale therapeutische Systeme enthaltend Sexualsteroide
AU5671496A (en) *	1995-05-15	1996-11-29	Beth Israel Hospital	Use of dihydrotestosterone compounds for treating male sexual dysfunction
US5783208A (en) *	1996-07-19	1998-07-21	Theratech, Inc.	Transdermal drug delivery matrix for coadministering estradiol and another steroid
KR100215027B1 (ko) *	1997-01-27	1999-08-16	성재갑	스테로이드계 약물의 경피흡수투여용 조성물 및 이를 포함하는 경피흡수투여용 제형
US20010023261A1 (en) *	1997-01-27	2001-09-20	Lg Chemical Limited.	Novel composition for the transdermal administration of drugs
DE19728517C2 (de) *	1997-07-04	1999-11-11	Sanol Arznei Schwarz Gmbh	TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung
US20020012694A1 (en) *	1997-09-17	2002-01-31	Alfred J. Moo-Young	Transdermal administration of ment
US5869090A (en) *	1998-01-20	1999-02-09	Rosenbaum; Jerry	Transdermal delivery of dehydroepiandrosterone
DE19827732A1 (de) *	1998-06-22	1999-12-23	Rottapharm Bv	Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
RU2234920C2 (ru) *	1999-06-11	2004-08-27	Уотсон Фармасьютикалс, Инк.	Введение непероральным путем андрогенных стероидов женщинам
GB2363984A (en) *	2000-06-29	2002-01-16	Hunter Fleming Ltd	Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
GB2363983A (en) *	2000-06-29	2002-01-16	Hunter Fleming Ltd	Protection against neuronal damage using 7-hydroxyepiandrosterone
IL154693A0 (en) *	2000-08-30	2003-09-17	Unimed Pharmaceuticals Inc	Method of increasing testosterone and related steroid concentrations in women
FR2818148B1 (fr) *	2000-12-15	2005-06-24	Oreal	Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide
US6510801B2 (en) *	2001-06-01	2003-01-28	Hong Sin Tan	Pallet for shrinkwrapped packaging of block rubber
GB2378898A (en) *	2001-08-14	2003-02-26	Hunter Fleming Ltd	Prophylactic and therapeutic use of hydroxysteroids
EP1607104B1 (en) *	2003-03-27	2015-12-09	COSMED Pharmaceutical Co. Ltd.	Pressure-sensitive adhesive for percutaneous absorption, pressure-sensitive adhesive composition for percutaneous absorption, and medicinal preparation for percutaneous absorption

2004
- 2004-04-28 GB GBGB0409498.3A patent/GB0409498D0/en not_active Ceased
- 2004-04-28 US US11/568,387 patent/US20070231373A1/en not_active Abandoned
2005
- 2005-04-27 TW TW094113457A patent/TWI354557B/zh not_active IP Right Cessation
- 2005-04-28 DE DE602005023436T patent/DE602005023436D1/de not_active Expired - Lifetime
- 2005-04-28 DK DK05738733.4T patent/DK1748779T3/da active
- 2005-04-28 RU RU2006141830/15A patent/RU2371183C2/ru not_active IP Right Cessation
- 2005-04-28 CN CN2005800175630A patent/CN1997375B/zh not_active Expired - Fee Related
- 2005-04-28 ES ES05738733T patent/ES2352202T3/es not_active Expired - Lifetime
- 2005-04-28 PL PL05738733T patent/PL1748779T3/pl unknown
- 2005-04-28 KR KR1020067024617A patent/KR101139023B1/ko not_active Expired - Fee Related
- 2005-04-28 NZ NZ550784A patent/NZ550784A/en not_active IP Right Cessation
- 2005-04-28 JP JP2007510103A patent/JP4849478B2/ja not_active Expired - Fee Related
- 2005-04-28 EP EP05738733A patent/EP1748779B1/en not_active Expired - Lifetime
- 2005-04-28 CA CA2563830A patent/CA2563830C/en not_active Expired - Fee Related
- 2005-04-28 HR HR20100558T patent/HRP20100558T1/hr unknown
- 2005-04-28 WO PCT/GB2005/001596 patent/WO2005105104A1/en not_active Ceased
- 2005-04-28 PT PT05738733T patent/PT1748779E/pt unknown
- 2005-04-28 AU AU2005237285A patent/AU2005237285B2/en not_active Ceased
- 2005-04-28 SI SI200531179T patent/SI1748779T1/sl unknown
- 2005-04-28 AT AT05738733T patent/ATE480241T1/de active
2006
- 2006-10-22 IL IL178781A patent/IL178781A/en not_active IP Right Cessation
- 2006-10-25 ZA ZA200608878A patent/ZA200608878B/xx unknown
- 2006-11-27 NO NO20065440A patent/NO337073B1/no not_active IP Right Cessation
2010
- 2010-12-01 CY CY20101101106T patent/CY1111318T1/el unknown

Also Published As

Publication number	Publication date
US20070231373A1 (en)	2007-10-04
NZ550784A (en)	2010-03-26
PT1748779E (pt)	2010-11-02
JP4849478B2 (ja)	2012-01-11
IL178781A0 (en)	2007-05-15
ES2352202T3 (es)	2011-02-16
GB0409498D0 (en)	2004-06-02
HRP20100558T1 (hr)	2010-11-30
CA2563830C (en)	2013-01-15
ZA200608878B (en)	2008-07-30
WO2005105104A1 (en)	2005-11-10
NO337073B1 (no)	2016-01-18
EP1748779B1 (en)	2010-09-08
ATE480241T1 (de)	2010-09-15
PL1748779T3 (pl)	2011-03-31
CA2563830A1 (en)	2005-11-10
CN1997375B (zh)	2010-09-22
TWI354557B (en)	2011-12-21
AU2005237285A1 (en)	2005-11-10
RU2371183C2 (ru)	2009-10-27
KR20070004995A (ko)	2007-01-09
RU2006141830A (ru)	2008-06-10
AU2005237285B2 (en)	2010-10-14
CN1997375A (zh)	2007-07-11
NO20065440L (no)	2006-11-27
DE602005023436D1 (de)	2010-10-21
TW200538133A (en)	2005-12-01
HK1096606A1 (en)	2007-06-08
SI1748779T1 (sl)	2011-01-31
EP1748779A1 (en)	2007-02-07
KR101139023B1 (ko)	2012-04-26
CY1111318T1 (el)	2015-08-05
JP2007534734A (ja)	2007-11-29
IL178781A (en)	2013-10-31

Publication	Publication Date	Title
EP2135908A3 (en)	2014-09-03	Pressure-sensitive adhesive composition and pressure-sensitive adhesive sheet to be attached to metal surface
BRPI0818353A2 (pt)	2015-04-07	Dispersões aquosas incluindo resina alquídica e polímero de adição tendo segmento(met)acrilato
TW200504169A (en)	2005-02-01	Pressure-sensitive adhesive for surface-protective film and surface-protective film
EP2135906A3 (en)	2014-09-03	Pressure-sensitive adhesive composition and use thereof
EP2135907A3 (en)	2014-09-03	Pressure-sensitive adhesive composition, pressure-sensitive adhesive sheet, and method for producing the same
EP2492330A3 (en)	2012-09-05	Removable Water-Dispersible Acrylic Pressure-Sensitive Adhesive Composition and Pressure-Sensitive Adhesive Sheet
JP2012153772A5 (da)	2014-01-30
ATE508166T1 (de)	2011-05-15	Copolymermischung
ATE404250T1 (de)	2008-08-15	Copolymere auf basis von tert.-butyl(meth)acrylat und deren verwendung in haarsprays
BR112014017650A8 (pt)	2017-07-11	Uso de ésteres de forbol para tratar ou prevenir um ou mais dos sintomas da doença de parkinson
WO2009052411A3 (en)	2009-07-30	Methods for treatment of thiol-containing compound deficient conditions
ATE542870T1 (de)	2012-02-15	Feste druckempfindliche gummihaftzusammensetzung und druckempfindliche haftfolie daraus
RU2008144405A (ru)	2010-05-20	Содержащий тамсулозин трансдермальный пластырь
WO2009120412A3 (en)	2011-04-07	Adhesive composition having non-tacky microspheres and sheets made therefrom
BR112013027484A2 (pt)	2017-01-10	composição farmacêutica ou nutracêutica com resistência gástrica com resistência contra a influência do etanol
EP2324860A3 (en)	2013-12-25	Medical pressure-sensitive adhesive composition
JP2006517603A5 (da)	2007-03-08
ATE437210T1 (de)	2009-08-15	Haftkleber und klebepflaster
JP2016094616A5 (da)	2018-01-25
CY1111318T1 (el)	2015-08-05	Διαδερματικη φαρμακοτεχνικη μορφη στεροειδους
MY209552A (en)	2025-07-19	Hot-melt adhesive composition
WO2012136818A3 (en)	2014-02-06	Cosmetic composition comprising a cucurbic acid compound and a blend of acrylic polymers
DE602005008189D1 (de)	2008-08-28	Haftklebstoffzusammensetzung und hautpflaster
DE602005020996D1 (de)	2010-06-10	Kaugummi und gummibasis enthaltend styrol-isopren-styrol-copolymere
WO2006103568A3 (en)	2007-03-29	NEW CLASS OF Ϝδ T CELLS ACTIVATORS AND USE THEREOF